Transplant Surgery »  Research »  Clinical Research »  Clinical Trials
 
Division Programs
Dept. of Surgery Websites

Message from the Chief

John P. Roberts, M.D.

Professor & Chief,
Division of Transplant Surgery

Read message »

Make a Gift

Support the Transplant Surgery Program in the quest to discover new treatments for diseases of the kidney, liver and pancreas and to improve transplantation outcomes.

How you can help »

The Nathan Bass UCSF Liver Transplant Conference - 2012

The Annual Conference at The Siverado in Napa features an outstanding group of faculty, led by Francis Y.K. Yao, M.D., discussing the latest developments in liver transplantation and liver disease.

View the brochure >>
 

UCSF Study Shows that Deadly Liver Cancer May Be Triggered by Cells Changing Identity

Holger Willenbring, M.D., Ph.D., and researchers from his lab show that cholangiocarcinomas, also known as bile duct cancers, may actually develop when one type of liver cell morphs into a totally different type, a process scientists used to consider all but impossible.

Read more >>
Transplant Surgery »  Research »  Clinical Research »  Clinical Trials

Transplant Surgery Clinical Trials

The Division of Transplant Surgery has a thriving research program with a broad portfolio of clinical trials. These are led by Principal Investigators (PI) conducting research to support advances in treatment, supported by a professional staff of trial coordinators and clinical research nurses. Below is a list of active trials including enrollment status and contact information for the study. 

   Also show trials not enrolling patients
Select by Type: 

Acute Liver Failure (Pediatric)

Recruiting
A Multi-Center Group to Study Acute Liver Failure in Children
Study ID: PALF
Principal Investigator:
Philip Rosenthal, M.D.
Enrolling patients
Active, not recruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingRecruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingEnrolling by invitationRecruitingRecruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingNot yet recruitingActive, but closed to enrollmentRecruitingRecruiting

Biliary Atresia

RecruitingActive, not recruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingActive, but closed to enrollmentRecruiting
Biliary Atresia Research Consortium
Study ID: BARC-PROBE
Principal Investigator:
Philip Rosenthal, M.D.
Enrolling patients
RecruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingEnrolling by invitationRecruitingRecruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingNot yet recruitingActive, but closed to enrollmentRecruitingRecruiting

Carcinoid Tumor

RecruitingActive, not recruitingRecruiting
A Study of Axitinib in Advanced Carcinoid Tumors
Study ID: UCSF-114520
Principal Investigator:
Emily Bergsland, M.D.
Enrolling patients
RecruitingActive, not recruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingRecruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingEnrolling by invitationRecruitingRecruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingNot yet recruitingActive, but closed to enrollmentRecruitingRecruiting

Chronic Kidney Disease

RecruitingActive, not recruitingRecruitingRecruiting
A Study of Fresolimumab in Patients With Steroid-Resistant Primary Focal Segmental Glomerulosclerosis (FSGS)
Study ID: GC1008FSGS03110
Principal Investigator:
Flavio Vincenti, M.D.
Enrolling patients
Active, not recruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingRecruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingEnrolling by invitationRecruitingRecruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingNot yet recruitingActive, but closed to enrollmentRecruitingRecruiting

Chronic Liver Disease

RecruitingActive, not recruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingRecruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingEnrolling by invitationRecruiting
Safety and Pharmacokinetics of Ifetroban in Hepatorenal Syndrome Patients
Study ID: HRS
Principal Investigator:
Sandy Feng, M.D., Ph.D.
Enrolling patients
RecruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingNot yet recruitingActive, but closed to enrollmentRecruitingRecruiting

Colorectal Cancer

RecruitingActive, not recruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingRecruitingRecruiting
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Study ID: UCSF-12451
Principal Investigator:
Nicholas Fidelman, M.D.
Enrolling patients
RecruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingEnrolling by invitationRecruitingRecruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingNot yet recruitingActive, but closed to enrollmentRecruiting
Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases
Study ID: UCSF-08451-B
Principal Investigator:
Nicholas Fidelman, M.D.
Enrolling patients
Recruiting

Hepatocellular Carcinoma (Primary Liver Cancer)

RecruitingActive, not recruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingRecruiting
Chemoembolization With or Without Sorafenib Tosylate in Treating Patients With Liver Cancer That Cannot Be Removed By Surgery
Study ID: ECOG-E1208
Principal Investigator:
Alan P. Venook, M.D.
Enrolling patients
RecruitingRecruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruiting
Phase II Combination of Temsirolimus and Sorafenib in Advanced Hepatocellular Carcinoma
Study ID: UCSF-124511
Principal Investigator:
R. Kate (Katie) Kelley, M.D.
Enrolling patients
Active, not recruitingRecruitingRecruitingRecruitingEnrolling by invitationRecruitingRecruiting
Sorafenib Tosylate With or Without Doxorubicin Hydrochloride in Treating Patients With Locally Advanced or Metastatic Liver Cancer
Study ID: CALGB-80802
Principal Investigator:
Alan P. Venook, M.D.
Enrolling patients
Active, but closed to enrollmentActive, not recruitingActive, not recruitingRecruiting
Study of REGN910 (SAR307746)
Study ID: UCSF-09455
Principal Investigator:
R. Kate (Katie) Kelley, M.D.
Enrolling patients
Active, not recruitingNot yet recruitingActive, but closed to enrollmentRecruitingRecruiting
Yttrium-90 Radioembolization With Glass Microspheres (TheraSphere) for Patients With Hepatocellular Carcinoma
Study ID: UCSF-08451-A
Principal Investigator:
Nicholas Fidelman, M.D.
Enrolling patients

Islet Cell Transplant

RecruitingActive, not recruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingRecruitingRecruitingRecruiting
Efficacy of Islet After Kidney Transplantation
Study ID: DAIT CIT-06
Principal Investigator:
Andrew M. Posselt, M.D., Ph.D., FACS
Enrolling patients
Active, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingEnrolling by invitationRecruitingRecruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingNot yet recruitingActive, but closed to enrollmentRecruitingRecruiting

Kidney Transplant

RecruitingActive, not recruitingRecruitingRecruitingActive, not recruitingRecruitingRecruiting
An Observational Study on Spermatogenesis in Male Renal Transplant Recipients Receiving Valcyte (Valganciclovir) Versus Untreated Matched Controls
Study ID: WV25651
Principal Investigator:
Flavio Vincenti, M.D.
Enrolling patients
Active, but closed to enrollmentRecruitingRecruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruiting
Hyperglycemia in Renal Transplantation
Study ID: HiRT (042918)
Principal Investigator:
Enrolling patients
Recruiting
I5NP for Prophylaxis of Delayed Graft Function in Kidney Transplantation
Study ID: QRK.006 Part B (Quark)
Principal Investigator:
Sandy Feng, M.D., Ph.D.
Enrolling patients
RecruitingActive, not recruitingActive, not recruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingRecruiting
Reference Group Trial for The ONE Study
Study ID: Reference Group Trial for The ONE Study
Principal Investigator:
Flavio Vincenti, M.D.
Enrolling patients
Recruiting
Research Study of ATG and Rituximab in Renal Transplantation
Study ID: RESTARRT
Principal Investigator:
Andrew M. Posselt, M.D., Ph.D., FACS
Enrolling patients
Recruiting
Safety & Efficacy of Eculizumab to Prevent AMR in Living Donor Kidney Transplant Recipients Requiring Desensitization
Study ID: C10-001
Principal Investigator:
Flavio Vincenti, M.D.
Enrolling patients
Enrolling by invitation
Safety and Efficacy Study of Everolimus to Treat BK Virus Infection in Kidney Transplant Recipients
Study ID: CRAD001AUS184T
Principal Investigator:
David Wojciechowski, D.O.
RecruitingRecruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingNot yet recruiting
Transversus Abdominis Plane (TAP) Block After Kidney Transplantation
Study ID: 11-06622
Principal Investigator:
Matthias R. Braehler, M.D.
Not yet enrolling
Active, but closed to enrollmentRecruitingRecruiting

Liver Metastases

RecruitingActive, not recruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingRecruitingRecruiting
Efficacy Evaluation of TheraSphere Following Failed First Line Chemotherapy in Metastatic Colorectal Cancer
Study ID: UCSF-12451
Principal Investigator:
Nicholas Fidelman, M.D.
Enrolling patients
RecruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingEnrolling by invitationRecruitingRecruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingNot yet recruitingActive, but closed to enrollmentRecruiting
Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases
Study ID: UCSF-08451-B
Principal Investigator:
Nicholas Fidelman, M.D.
Enrolling patients
Recruiting

Liver Transplant

RecruitingActive, not recruitingRecruitingRecruitingActive, not recruitingRecruiting
Adult-to-Adult Living Donor Transplant Cohort Study
Study ID: A2ALL
Principal Investigator:
Chris E. Freise, M.D.
Enrolling patients
RecruitingActive, but closed to enrollmentRecruitingRecruitingRecruitingRecruitingActive, but closed to enrollmentRecruiting
Extension Study to Evaluate the Long-term Efficacy and Safety of Everolimus in Liver Transplant Recipients
Study ID: CRAD001H2304E1
Principal Investigator:
Enrolling patients
Active, not recruitingRecruitingRecruitingRecruiting
Immunosuppression Withdrawal for Stable Pediatric Liver Transplant Recipients
Study ID: iWITH
Principal Investigator:
Sandy Feng, M.D., Ph.D.
Enrolling patients
Active, not recruitingActive, not recruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingEnrolling by invitationRecruitingRecruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingNot yet recruitingActive, but closed to enrollmentRecruitingRecruiting

Melanoma

RecruitingActive, not recruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingRecruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingEnrolling by invitationRecruitingRecruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingNot yet recruitingActive, but closed to enrollmentRecruiting
Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases
Study ID: UCSF-08451-B
Principal Investigator:
Nicholas Fidelman, M.D.
Enrolling patients
Recruiting

Neuroendocrine Tumors

RecruitingActive, not recruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingRecruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingEnrolling by invitationRecruitingRecruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingNot yet recruitingActive, but closed to enrollmentRecruiting
Yttrium-90 Radioembolization Using Glass Microspheres (TheraSphere) for Patients With Liver Metastases
Study ID: UCSF-08451-B
Principal Investigator:
Nicholas Fidelman, M.D.
Enrolling patients
RecruitingRecruitingActive, not recruitingRecruitingRecruitingActive, not recruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingRecruitingRecruitingRecruitingActive, but closed to enrollmentRecruitingActive, not recruitingRecruitingRecruitingRecruitingActive, not recruitingActive, not recruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingRecruitingRecruitingRecruitingEnrolling by invitationRecruitingRecruitingActive, but closed to enrollmentActive, not recruitingActive, not recruitingRecruitingActive, not recruitingNot yet recruitingActive, but closed to enrollmentRecruitingRecruiting
X